Brain region | K1 (mL/mL/min) | VT (mL/mL) | BPND 2T arterial | BPND SRTM | BPND Logan reference | BPND SUVr method |
Caudate | 0.09 ± 0.01 | 3.18 ± 0.30 | 0.76 ± 0.14 | 0.68 ± 0.17 | 0.68 ± 0.15 | 0.76 ± 0.14 |
Putamen | 0.14 ± 0.07 | 3.90 ± 0.91 | 1.16 ± 0.44 | 1.03 ± 0.33 | 1.04 ± 0.33 | 1.12 ± 0.31 |
Striatum | 0.11 ± 0.04 | 3.58 ± 0.65 | 0.98 ± 0.31 | 0.86 ± 0.25 | 0.87 ± 0.24 | 0.94 ± 0.23 |
Frontal cortex | 0.09 ± 0.03 | 2.07 ± 0.18 | 0.15 ± 0.03 | 0.08 ± 0.04 | 0.08 ± 0.04 | 0.09 ± 0.02 |
Parietal cortex | 0.10 ± 0.03 | 2.07 ± 0.24 | 0.15 ± 0.06 | 0.11 ± 0.05 | 0.08 ± 0.02 | 0.09 ± 0.05 |
Temporal cortex | 0.11 ± 0.04 | 2.16 ± 0.19 | 0.20 ± 0.08 | 0.14 ± 0.06 | 0.14 ± 0.06 | 0.16 ± 0.06 |
Occipital cortex | 0.11 ± 0.03 | 2.01 ± 0.15 | 0.12 ± 0.06 | 0.09 ± 0.04 | 0.08 ± 0.02 | 0.09 ± 0.05 |
Cerebellum | 0.11 ± 0.02 | 1.80 ± 0.13 | — | — | — | — |
Highest VT and BPND values were determined in A2A-rich regions (i.e., caudate, putamen, and striatum) for all investigated methods. Results presented as mean ± SD (n = 3). BPND SUVr method determined as average between 90 and 150 min after injection.